Comera Life Sciences announces collaboration with QCL

Comera Life Sciences announced a partnership with Quality Chemical Laboratories, QCL, to manufacture one of Comera’s lead SQore excipients, as part of a broader strategy to secure the GMP manufacturing and supply chain of key proprietary technology owned by the Company. “QCL is pleased to leverage its strong synthetic and analytical chemistry expertise to advance Comera’s technology platform,” said Dr. Yousry Sayed, President and CEO of QCL. “There has been a growing trend towards bringing back manufacturing of critical, high-value technologies such as pharmaceuticals to the United States to reduce supply risk, ensure high quality production and improve regulatory compliance. We are pleased to work with Comera on this important initiative to help them secure the supply, distribution and quality of their key technologies.”